… is down-regulated in breast cancer tissues and linked to chemotherapy resistance [43]. …
the role of GAS5 in osteosarcoma with respect to chemotherapy-related resistance. However, …

… GAS5 regulated the chemotherapy resistance … GAS5 might act as a tumor-suppressing
gene in BTCC. However, none is known about the influence of GAS5 to chemotherapy resistance …

… expression may adversely impact upon the responses of breast cancer cells to certain
death-inducing stimuli, including conventional chemotherapeutic agents, and this resistance to …

… GAS5 is a potential therapeutic target in glioma, and may be related to chemotherapy resistance
… , Akt, PI3K, and mTOR may be closely involved in chemotherapy resistance in glioma. …

… and chemotherapeutic drugs, while GAS5 downregulation attenuates these effects. … in
CC cells (65), while GAS5 overexpression increases the resistance of CC cells to cisplatin by …

… and drug resistance result in poor … chemotherapy, while statistical studies have shown that
about 15 to 25% of EOC patients appeared primary resistant to platinum-based chemotherapy…

… two commonly used clinical chemotherapy drugs that form complexes with GAS5, were
tested on TNBC cell lines [55]. The expression of GAS5 was increased in PTX-resistant MDA-231-…

… To examine the effects of GAS5 expression on chemotherapeutic drug resistance, the
survival of CC cells transfected with lentivirus GAS5, GAS5 siRNAs, miR21 mimic, and miR-21 …

… revealed that overexpression of GAS5 sensitized HCT116 cells to chemotherapeutic agents,
which … (miR)-21, which induced regulation of cisplatin resistance (21). In pancreatic cancer, …

… To prove that GAS5 regulated miR-21 as a competitive endogenous RNA (ceRNA), we used
… In summary, we confirmed that GAS5 was connected with prognosis and chemotherapeutic …